Chemokines and ocular pathology caused by corneal infection with herpes simplex virus

References

• Avery A C, Zhao Z S, Rodriquez A, et al. Resistance to herpes stromal keratitis conferred by an IgG2a derived peptide. Nature 1995; 376: 431–434
   PubMedGoogle Scholar
• Babu J S, Rouse B T. Inflammatory disease in the T cell mediated immunopathology-the herpetic stromal keratitis example. Allergy Immunol (Life Sci Adv) 1996; 13: 109–116
   Google Scholar
• Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565–568
   PubMed Web of Science ®Google Scholar
• Bouley D M, Kanangat S, Wire W, et al. Characterization of herpes simplex virus type 1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J Immunol 1995; 155: 3964–3971
   PubMed Web of Science ®Google Scholar
• Chen W, Tang Q, Hendricks R L. Ex vivo model of leukocyte migration into herpes simplex-virus infected cornea. J Leuk Bio 1996; 60: 167–173
   PubMed Web of Science ®Google Scholar
• Cao Y, Chen C, Weatherbee J A, Tsang M, et al. Gro-β, A CXC chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carinoma in mice. J Exp Med 1995; 182: 2069–2078
   PubMed Web of Science ®Google Scholar
• Daheshia M, Kuklin N, Kanangat S, et al. Suppression of ongoing ocular inflammatory disease by tropical administration of plasmid DNA encoding IL-10. J Immunol 1997; 159: 1945–1952
   PubMed Web of Science ®Google Scholar
• Doymaz M Z, Rouse B T. Herpetic stromal keratitis: an immunopathological disease mediated by CD4+ Tlymphocytes. Invest Ophthalmol. Vis Sci 1992; 33: 2165–2173
   Google Scholar
• Fenwick M L, Clark J. Early and delayed shut-off of host protein synthesis in cells infected with herpes simplex virus. J Gen Virol 1982; 61: 121–127
   Google Scholar
• Ferguson T A, Griffith T S. Cell death and the immune response-a lesson from the privileged. J Clin Immunol 1997; 17: 1–10
   Google Scholar
• Hendricks R L, Tumpey T M. Contribution of virus and immune factors to herpes simplex virus type I induced corneal pathology. Invest Ophthalmol Vis Sci 1990; 31: 1929–1939
   PubMed Web of Science ®Google Scholar
• Hendricks R L, Tumpey T M, Finnegan A. IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice. J Immunol 1992a; 149: 3023–3028
   PubMed Web of Science ®Google Scholar
• Hendricks R L, Janowicz M, Tumpey T M. Critical role of corneal Langerhans cells in the CD4+ mediated but not CD8+ medited immunopathology in herpes simplex virus-1 infected corneas. J Immunol 1992b; 148: 2522–2529
   PubMed Web of Science ®Google Scholar
• Koch A E, Polverini P J, Kunkel S L, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798–1801
   PubMed Web of Science ®Google Scholar
• Liesegang T J. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989; 107: 1160–1165
   PubMed Web of Science ®Google Scholar
• Luster A D. Chemokines- chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436–445
   PubMed Web of Science ®Google Scholar
• Luster A D, Greenberg S M, Leder P. The IP-10 chemokine binds to a specific cell surface heparin sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995; 182: 219–231
   PubMed Web of Science ®Google Scholar
• Metcalf J F, Hamilton D S, Reichert R W. Herpetic keratitis in athymic (nude) mice. Infect Immunol 1979; 26: 1164–1171
   PubMed Web of Science ®Google Scholar
• Newell C K, Martin S, Sendele D, et al. Herpes simplex virus induced stromal keratitis: role of T lymphocyte subsets in immunopathology. J Virol 1989; 63: 769–775
   PubMed Web of Science ®Google Scholar
• Niemialtowski M G, Rouse B T. Predominance of Thl cells in ocular tissues during herpetic stromal keratitis. J Immunol 1992; 149: 3035–3039
   PubMed Web of Science ®Google Scholar
• Pearlman E, Lass J H, Bardenstein D S, et al. Interluekin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J Exp Med 1995; 182: 931–940
   PubMedGoogle Scholar
• Pepose J S, Leib D A, Stuart P M, . Herpes Simplex Virus diseases: anterior segment of the eye. Ocular Infection and Immunity, J S Pepose, G N Holland, K R Wilhelmus, et al. Mosby Press, St. Louis MO 1996; 905–932
   Google Scholar
• Rollins B J. Chemokines. Blood 1997; 90: 909–928
   PubMed Web of Science ®Google Scholar
• Rossi D L, Vicari A P, Franz-Bacon K, et al. Identification through bioinformatics of two new macrophage proinflammatory human chemokines MIP-3α and MIP-3β. J Immunol 1997; 158: 1033–1037
   PubMed Web of Science ®Google Scholar
• Russel R G, Nasisse M P, Larsen H S, et al. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol 1984; 25: 938–944
   Google Scholar
• Smith J, Hogaboam C M, Strieter R M. Cell to cell and cell to matrix interactions mediate chemokine expression: an improtant component of the inflammatory lesion. J Leukoc Biol 1997; 62: 612–619
   Google Scholar
• Streilein J W. Ocular immune privilege and the Faustian dilemma-the Proctor lecture. Invest Ophthalmol Vis Sci 1996; 37: 1940–1950
   PubMed Web of Science ®Google Scholar
• Streiter R M, Polverini P J, Arenberg D A, et al. Role of CXC chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 1995a; 57: 752–762
   Google Scholar
• Strieter R M, Polverini P J, Kunkel S L, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995b; 270: 27348–27357
   PubMed Web of Science ®Google Scholar
• Su Y H, Yan X T, Oaks J E, et al. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J Virol 1996; 70: 1277–1281
   PubMed Web of Science ®Google Scholar
• Thomas J, Rouse B T. Immunopathogenesis of Herpetic Ocular Disease. Immunologic Besearch 1997a; 16: 375–386
   PubMed Web of Science ®Google Scholar
• Thomas J, Gangappa S, Kanangat S, et al. On the essential involvement of neutrophils in the immunopathological disease-herpetic stromal keratitis. J Immunol 1997b; 158: 1383–1391
   PubMed Web of Science ®Google Scholar
• Thomas J, Kanangat S, Rouse B T. Herpes simplex virus replication induced expression of chemokines and proinflammatory cytokines in the eye-Implications in Herpetic Stromal Keratitis. J Interferon Cytokine Besearch 1998, In press
   Google Scholar
• Tumpey T M, Elner V M, Chen S H, et al. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol 1994; 153: 2258–2265
   PubMed Web of Science ®Google Scholar
• Tumpey T M, Chen S H, Oakes J E. Neutrophil mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol 1996; 70: 898–904
   PubMed Web of Science ®Google Scholar
• Tumpey T M, Cheng H, Yan D T, et al. Chemokine synthesis in the HSV infected cornea and its suppression by interleukin-10. J Leukoc Biol 1998a; 63: 486–492
   PubMed Web of Science ®Google Scholar
• Tumpey T M, Cheng H, Yan D T, et al. Absence of macrophage inflammatory protein lα prevent the development of blinding herpetic stromal keratitis. J Virol 1998b; 72: 3705–3710
   PubMed Web of Science ®Google Scholar
• WuDunn D, Spear P G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 1989; 63: 52–58
   PubMed Web of Science ®Google Scholar
• Yan X T, Tumpey T M, Kunkel S L, et al. MIP-2 is more potent than KC at inducing Neutrophil migration and tissue injury in the HSV-1 infected cornea. Invest Ophthalmol Vis Sci 1998, In press
   Google Scholar